207 related articles for article (PubMed ID: 19319191)
1. Adiponectin haploinsufficiency promotes mammary tumor development in MMTV-PyVT mice by modulation of phosphatase and tensin homolog activities.
Lam JB; Chow KH; Xu A; Lam KS; Liu J; Wong NS; Moon RT; Shepherd PR; Cooper GJ; Wang Y
PLoS One; 2009; 4(3):e4968. PubMed ID: 19319191
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol-induced mammary tumorigenesis is enhanced by adiponectin deficiency: role of LDL receptor upregulation.
Liu J; Xu A; Lam KS; Wong NS; Chen J; Shepherd PR; Wang Y
Oncotarget; 2013 Oct; 4(10):1804-18. PubMed ID: 24113220
[TBL] [Abstract][Full Text] [Related]
3. PTEN deficiency in a luminal ErbB-2 mouse model results in dramatic acceleration of mammary tumorigenesis and metastasis.
Schade B; Rao T; Dourdin N; Lesurf R; Hallett M; Cardiff RD; Muller WJ
J Biol Chem; 2009 Jul; 284(28):19018-26. PubMed ID: 19435886
[TBL] [Abstract][Full Text] [Related]
4. Enhanced genetic instability and dasatinib sensitivity in mammary tumor cells lacking NEDD9.
Singh MK; Izumchenko E; Klein-Szanto AJ; Egleston BL; Wolfson M; Golemis EA
Cancer Res; 2010 Nov; 70(21):8907-16. PubMed ID: 20940402
[TBL] [Abstract][Full Text] [Related]
5. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.
Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM
Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799
[TBL] [Abstract][Full Text] [Related]
6. Redox regulation of the tumor suppressor PTEN by the thioredoxin system and cumene hydroperoxide.
Han SJ; Zhang Y; Kim I; Chay KO; Yoon HJ; Jang DI; Yang SY; Park J; Woo HA; Park I; Lee SR
Free Radic Biol Med; 2017 Nov; 112():277-286. PubMed ID: 28774816
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
[TBL] [Abstract][Full Text] [Related]
8. Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling.
Korkaya H; Paulson A; Charafe-Jauffret E; Ginestier C; Brown M; Dutcher J; Clouthier SG; Wicha MS
PLoS Biol; 2009 Jun; 7(6):e1000121. PubMed ID: 19492080
[TBL] [Abstract][Full Text] [Related]
9. Transforming acidic coiled coil 1 promotes transformation and mammary tumorigenesis.
Cully M; Shiu J; Piekorz RP; Muller WJ; Done SJ; Mak TW
Cancer Res; 2005 Nov; 65(22):10363-70. PubMed ID: 16288026
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo anti-malignant melanoma activity of Alocasia cucullata via modulation of the phosphatase and tensin homolog/phosphoinositide 3-kinase/AKT pathway.
Fang M; Zhu D; Luo C; Li C; Zhu C; Ou J; Li H; Zhou Y; Huo C; Liu W; Peng J; Peng Q; Mo Z
J Ethnopharmacol; 2018 Mar; 213():359-365. PubMed ID: 29180042
[TBL] [Abstract][Full Text] [Related]
11. Mislocalization of the cell polarity protein scribble promotes mammary tumorigenesis and is associated with basal breast cancer.
Feigin ME; Akshinthala SD; Araki K; Rosenberg AZ; Muthuswamy LB; Martin B; Lehmann BD; Berman HK; Pietenpol JA; Cardiff RD; Muthuswamy SK
Cancer Res; 2014 Jun; 74(11):3180-94. PubMed ID: 24662921
[TBL] [Abstract][Full Text] [Related]
12. In MMTV-Her-2/neu transgenic mammary tumors the absence of caveolin-1-/- alters PTEN and NHERF1 but not β-catenin expression.
Cuello-Carrión FD; Cayado-Gutiérrez N; Natoli AL; Restall C; Anderson RL; Nadin S; Alvarez-Olmedo D; Castro GN; Gago FE; Fanelli MA; Ciocca DR
Cell Stress Chaperones; 2013 Sep; 18(5):559-67. PubMed ID: 23397229
[TBL] [Abstract][Full Text] [Related]
13. Stat5 regulates the phosphatidylinositol 3-kinase/Akt1 pathway during mammary gland development and tumorigenesis.
Schmidt JW; Wehde BL; Sakamoto K; Triplett AA; Anderson SM; Tsichlis PN; Leone G; Wagner KU
Mol Cell Biol; 2014 Apr; 34(7):1363-77. PubMed ID: 24469394
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
Ramírez-Moya J; Wert-Lamas L; Santisteban P
Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
[TBL] [Abstract][Full Text] [Related]
15. Activation of the phosphatidylinositol 3'-kinase/AKT pathway in neuroblastoma and its regulation by thioredoxin 1.
Sartelet H; Rougemont AL; Fabre M; Castaing M; Duval M; Fetni R; Michiels S; Beaunoyer M; Vassal G
Hum Pathol; 2011 Nov; 42(11):1727-39. PubMed ID: 21641013
[TBL] [Abstract][Full Text] [Related]
16. Acrolein-induced activation of mitogen-activated protein kinase signaling is mediated by alkylation of thioredoxin reductase and thioredoxin 1.
Randall MJ; Spiess PC; Hristova M; Hondal RJ; van der Vliet A
Redox Biol; 2013; 1(1):265-75. PubMed ID: 24024160
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor α induces down-regulation of PTEN through PI3-kinase activation in breast cancer cells.
Noh EM; Lee YR; Chay KO; Chung EY; Jung SH; Kim JS; Youn HJ
Mol Med Rep; 2011; 4(2):215-9. PubMed ID: 21468554
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer.
Denzel MS; Hebbard LW; Shostak G; Shapiro L; Cardiff RD; Ranscht B
Clin Cancer Res; 2009 May; 15(10):3256-64. PubMed ID: 19447866
[TBL] [Abstract][Full Text] [Related]
19. Thioredoxin reductase 1 and NADPH directly protect protein tyrosine phosphatase 1B from inactivation during H
Dagnell M; Pace PE; Cheng Q; Frijhoff J; Östman A; Arnér ESJ; Hampton MB; Winterbourn CC
J Biol Chem; 2017 Sep; 292(35):14371-14380. PubMed ID: 28684416
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
